Back to MW Marshall Wace, LLP

QNCXQNCX

Showing 3 of 13 quarters

Position history for MWMarshall Wace, LLP's holdings in QUINCE THERAPEUTICS INC

No. Marshall Wace exited its QNCX (Quince Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 511,858 shares worth $1.7M. Marshall Wace first reported QNCX in Q1 2020 and held it in 9 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$342,372

Total Shares Change

-210,045

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$20.20
0
2025-Q4
Increased
511,858
+143.7%
$1.7M0.0%$670.00
41
2025-Q3
New
210,045
—
$342,3720.0%$326.00
33

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used